Mississippi Procurement Portal #3150006788

Consultant Pharmacist Services for Boswell Regional Center and Group Homes

This opportunity involves the Mississippi State Department of Mental Health's Boswell Regional Center seeking a qualified Consultant Pharmacist for pharmacy consulting services at its main campus and group homes. - Government Buyer: - Mississippi State Department of Mental Health - Boswell Regional Center - Services Requested: - Consultant Pharmacist Services - Weekly visits to main campus and group homes in Bay Springs, Taylorsville, Magee, Wesson, and Brookhaven - Monthly drug regimen reviews for each client - Annual pharmacy evaluations - Inspections of drug storage areas and refrigerators - Monitoring compliance with federal and state pharmaceutical regulations - Checking emergency kits and conducting random checks of controlled drugs and medication containers - Making recommendations on medication regimens - Assisting with destruction and reconciliation of unused controlled substances - Minimum Qualifications: - Graduation from an accredited pharmacy school - Valid Mississippi pharmacy license - Controlled substance license - At least three years of experience as a licensed pharmacist - Contract Details: - Firm fixed price agreement - Five-year term - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a professional services solicitation - Unique Requirements: - Services must be performed at multiple locations, including the main campus and group homes across several cities - Strict compliance with all federal and state pharmaceutical regulations is required

Description

Boswell Regional Center is soliciting qualifications for a Consultant Pharmacist to provide pharmacy consulting services for its main campus and group homes located in Bay Springs, Taylorsville, Magee, Wesson, and Brookhaven, Mississippi. The consultant will perform weekly visits, monitor drug regimens monthly, conduct annual pharmacy evaluations, inspect drug storage areas, and ensure compliance with federal and state pharmaceutical regulations. The contract is a firm fixed price type, starting July 1, 2026, for a five-year term. Interested parties must submit a statement of qualifications and price proposal by April 24, 2026.

View original listing